Keyword Suggestion
Domain Informations
Network
- inetnum : 45.223.0.0 - 45.223.255.255
- name : INCAPSULA-NET
- handle : NET-45-223-0-0-1
- status : Direct Allocation
- created : 2010-09-15
- changed : 2025-11-12
- desc : -----BEGIN CERTIFICATE-----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-----END CERTIFICATE-----
Owner
- organization : Incapsula Inc
- handle : INCAP-5
- address : Array,SAN MATEO,CA,94403,US
Technical support
- handle : NETEN40-ARIN
- name : NetEng
- phone : +1-650-345-9000
- email : [email protected]
Abuse
- handle : ABUSE9265-ARIN
- name : Abuse
- phone : +1-650-345-9000
- email : [email protected]
| Domain Provider | Number Of Domains |
|---|---|
| godaddy.com | 286730 |
| namecheap.com | 101387 |
| networksolutions.com | 69118 |
| tucows.com | 52617 |
| publicdomainregistry.com | 39120 |
| whois.godaddy.com | 32793 |
| enomdomains.com | 23825 |
| namesilo.com | 21429 |
| domains.google.com | 21384 |
| cloudflare.com | 20573 |
| gmo.jp | 18110 |
| name.com | 17601 |
| fastdomain.com | 14708 |
| register.com | 13495 |
| net.cn | 12481 |
| ionos.com | 12416 |
| ovh.com | 12416 |
| gandi.net | 12305 |
| registrar.amazon.com | 12111 |
Host Informations
- IP address: 45.223.163.166
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Site Inspections
Port Scanner (IP: 45.223.163.166)
Spam Check (IP: 45.223.163.166)
Recent Searched Sites
› Automechanika-istanbul.tr.messefrankfurt.com (3 seconds ago) / DE
› Mbuksgdb.ru (14 seconds ago) / RU
› Filmoflix-hd98o.s3.amazonaws.com (1 seconds ago) / US
› Timeovate.com (5 seconds ago) / US
› Thefashionhub.in (12 seconds ago) / IN
› Nascentventures.nl (7 seconds ago) / NL
› Patient.boehringer-ingelheim.com (0 seconds ago) / US
› Kaliamusic.com (1 seconds ago) / JP
› Stcatharineschool.org (1 seconds ago) / US
› Dnstech.vn (0 seconds ago) / US
› Phimmoi.co (13 seconds ago) / US
› Pattern-cad.com (3 seconds ago) / KR
› Link.utkarsh.com (4 seconds ago) / US
› Astronilmani.in (2 seconds ago) / NL
› 2013.icg1688.com (5 seconds ago) / US
› Ehonmirai-lab.com (5 seconds ago) / JP
› Exmarkets.digital (1 seconds ago) / NL
› Nickldown.com (12 seconds ago) / CA
› Wiki.basestation.space (0 seconds ago) / US
› Paul.reviews (1 seconds ago) / US
Websites Listing
We found Websites Listing below when search with patient.boehringer-ingelheim.com on Search Engine
Contact Form | boehringer-ingelheim.ca
Please check that your email address is in the proper format e.g [email protected]. Telephone number * Select your country * Province * Is the product for * Product name * Clinic name (if applicable) Please speak with your veterinarian. Thank you for your interest in seeking funding from Boehringer Ingelheim Canada. If you would like to apply to request a donation, please …
Boehringer-ingelheim.caBoehringer Ingelheim Email Format | boehringer …
10 rows · The most common Boehringer Ingelheim email format is first '.' last (ex. …
Rocketreach.coBoehringer Ingelheim Canada and the pan-Canadian ...
2022-02-15 · Boehringer Ingelheim is working on breakthrough therapies that improve the lives of humans and animals. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since Boehringer Ingelheim takes a long-term perspective. Approximately …
Boehringer-ingelheim.caBoehringer Ingelheim - Value Through Innovation
Boehringer Ingelheim is engaged at various levels of action to contain and cope with the global spread of COVID-19. Read more on COVID-19. Vision. Our vision The Boehringer Ingelheim group of companies' objectives and beliefs can be summed up in a single phrase: Value through Innovation, the central concept of our corporate vision. Read more on Our vision - Animal …
Boehringer-ingelheim.caLogin | boehringer-ingelheim.in
Enter the password that accompanies your username. Request new password. Home
Boehringer-ingelheim.inBoehringer Ingelheim Canada and the pan-Canadian ...
2022-02-15 · 1 Ofev® Product Monograph. Boehringer Ingelheim (Canada) Ltd. July 5, 2021. 2 Wijsenbeek M, et al. Non-IPF progressive fibrosing interstitial lung diseases: the patient journey. Poster presented ...
Newswire.caWhen a Patient Becomes an Ambassador - Boehringer Ingelheim
2019-02-27 · “I joined Boehringer Ingelheim as a communication and patient advocacy relations manager because of their ambitious research and development program, and I am very proud to work for the company.” To her, it really matters to reach the patients. “My personal experience has told me one important lesson: The only way any of us can really understand the impact that we …
Careers.boehringer-ingelheim.comSHRF and Boehringer Ingelheim Partner to Improve Chronic ...
2021-08-31 · Boehringer Ingelheim is working on breakthrough therapies that improve the lives of humans and animals. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. …
Shrf.caPatient Stories | Pradaxa® | Boehringer Ingelheim
Explore real-world evidence data and patient stories surrounding the efficacy, safety and reversibility of PRADAXA for NVAF patients. header For Healthcare Professionals. About Us Opens in new tab. Global Website Opens in new tab. Contact Opens ...
Pro.boehringer-ingelheim.comBoehringer Ingelheim hiring Data Domain Owner (Remote ...
At Boehringer Ingelheim we create value through innovation with one clear goal: to improve the lives of patients. We develop breakthrough therapies and innovative healthcare solutions in areas of ...
Linkedin.comBoehringer Ingelheim email format | Boehringer Ingelheim ...
Boehringer ingelheim uses 12 email formats: 1. (firstname).(lastname) ([email protected]). Enter a name to find and verify an email
Aeroleads.comWelcome to ASK BI | Boehringer Ingelheim
Boehringer Ingelheim (Canada) Ltd./Ltée. uses a variety of measures to protect the personal information it collects, including physical, organizational and technological measures. Any personal information will be treated by Boehringer Ingelheim (Canada) Ltd./Ltée. in accordance with the Personal Information Protection and Electronic Documents Act (PIPEDA) and …
Askbi.caBoehringer-Ingelheim Launches Patient-Centric ...
2020-02-18 · Boehringer Ingelheim offers MyStudyWindow to provide patients, families, caregivers, and doctors consistent access to information about Boehringer Ingelheim’s actively recruiting studies conducted at global site locations ; The platform features patient-centric study titles and descriptions, educational content, and guidance on the clinical trial selection and …
Financialpost.comBoehringer Ingelheim - News & Information
2011-02-07 · Boehringer Ingelheim And Micromet Announce Cooperation For Experimental Multiple Myeloma Treatment – Boehringer Ingelheim and Micromet announced last week that they will collaborate on the development of BiTE antibodies for the treatment of multiple myeloma. BiTE antibodies, which were discovered by Micromet, target the body’s immune system …
Myelomabeacon.orgBoehringer Ingelheim, IBM to integrate blockchain tech in ...
2022-02-05 · Boehringer Ingelheim (Canada) Ltd. and IBM Canada aim to test whether blockchain technology in clinical trials provides a decentralized framework that enables data integrity, provenance, transparency, and patient empowerment as well as automation of processes, ultimately improving trial quality and patient safety at reduced cost.
Biospectrumasia.comBoehringer Ingelheim, Alberta Create Partnership to ...
2019-06-18 · Boehringer Ingelheim, the University Hospital Foundation, and the Government of Alberta, Canada, have formed a partnership aimed at implementing effective solutions to improve the lives of people with respiratory diseases, particularly chronic obstructive pulmonary disease (COPD).. The Alberta Boehringer Ingelheim Collaboration (ABIC) was recently announced at …
Copdnewstoday.com
Domains Expiration Date Updated
| Site | Provider | Expiration Date |
|---|---|---|
| wizard.ca | internic.ca | -3 Years, -232 Days |
| mooshima.com | webnic.cc | -3 Years, -166 Days |
| mach-b.com | godaddy.com | -3 Years, -211 Days |
| ietcapital.com | godaddy.com | -3 Years, -257 Days |
| furupaka.com | gmo.jp | -3 Years, -21 Days |
| yoderculpfuneralhome.com | godaddy.com | -3 Years, -164 Days |
| staad-arab.com | godaddy.com | -2 Years, -359 Days |
| soulbreezebeachresort.com | netearthone.com | -3 Years, -312 Days |
| omnitrans.org | networksolutions.com | 1 Year, 42 Days |
| shyminer.com | namecheap.com | -3 Years, -29 Days |